Dr. Michael D. Kommor, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Louisville School of Medicine (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 567
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: University of Louisville School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
KY license 27861
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Health Louisville Louisville, KY
- Baptist Health Hardin Elizabethtown, KY
- Baptist Health Floyd New Albany, IN
- Baptist Health Lagrange La Grange, KY
Medical groups
- Baptist Health Medical Group Inc (2,472 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 567
- Services billed
- 1,563
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 628 | 299 |
| Established patient office or other outpatient visit, 20-29 minutes | 248 | 202 |
| Established patient office or other outpatient visit, 40-54 minutes | 241 | 114 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 151 | 84 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 111 | 63 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 42 | 41 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 39 | 25 |
| New patient office or other outpatient visit, 45-59 minutes | 19 | 19 |
| New patient office or other outpatient visit, 60-74 minutes | 19 | 19 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 17 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Louisville, KY | 136 |
| Xarelto (rivaroxaban) Other prescribers in Louisville, KY | 124 |
| Eliquis (apixaban) Other prescribers in Louisville, KY | 115 |
| Acyclovir Other prescribers in Louisville, KY | 96 |
| Warfarin Sodium Other prescribers in Louisville, KY | 77 |
| Anastrozole Other prescribers in Louisville, KY | 69 |
| Tamoxifen Citrate Other prescribers in Louisville, KY | 63 |
| Imbruvica (ibrutinib) | 60 |
| Prednisone Other prescribers in Louisville, KY | 56 |
| Dexamethasone Other prescribers in Louisville, KY | 54 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 25 payments worth $538 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $208 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $84.36 |
| Astellas Pharma US Inc | $63.79 |
| Merck Sharp & Dohme LLC | $39.15 |
| AbbVie Inc. | $34.56 |
| Celgene Corporation | $24.05 |
| Gilead Sciences, Inc. | $24.00 |
| Daiichi Sankyo Inc. | $23.82 |
| Food and Beverage | $538 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.